Rephonic
Artwork for Pharma Market Access Insights

Pharma Market Access Insights - from Petauri Evidence

Petauri Evidence
NHS
Market Access
Real-World Evidence
Health Economics
Health Technology Assessment
Market Access Strategies
Rare Diseases
Primary Care
Petauri Evidence
Market Access Strategy
GP Contracts
Healthcare Inequalities
General Practice Networks
Integrated Care Systems
Winter Planning
Electronic Health Records
Partition Survival Model
Medical Devices
US Payers
Pharmaceutical Industry

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.

PublishesMonthlyEpisodes70Founded5 years ago
Number of ListenersCategories
ScienceLife SciencesBusiness

Listen to this Podcast

Artwork for Pharma Market Access Insights

Latest Episodes

Send us a text

In this NHS Whispers live Q&A webinar, Katie Mulholland (Senior Consultant, UK Market Access, Petauri Evidence) speaks to:

 - Sarah Everest Ford (Programme Director, Health and Care Partnership)

 - Patrick McGee (Deputy Programme Dire... more

Send us a text

Uncover the forces driving change in global pricing and access

In this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).

At Petauri Evidence,... more

Send us a text

Discover a smarter way to manage and share market access resources with local affiliates

Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? In this webinar we discussed ... more

Send us a text

What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you prepare for launch in a market as di... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Tim Styche
Health Outcomes Director
Smith and Nephew
Episode: Transforming Global Market Access: Smarter Resource Management with Local Affiliates
Dan Vanderpool
An expert in market access with experience in payer strategy and negotiation.
Petauri Advisors
Episode: Communicating value to US Payers: Insights for Pharma and Medtech
Rory Davies
Pharmacy director with extensive experience in managed care and cost management.
Petauri Advisors
Episode: Communicating value to US Payers: Insights for Pharma and Medtech
Jo Turl
Over 20 years in the NHS, with experience in commissioning acute and mental health services, and focus on community care and primary networks.
Independent Consultant working closely with NHS
Episode: NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas
Dr. Faris Al-Ramadani
Former primary care network clinical director and GP
Episode: De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
Don Husereau
Health economist and advisor on health policy, with experience in health technology assessment at CADTH.
University of Ottawa
Episode: Market access and reimbursement in Canada – changes at CADTH

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice
Q: Do you think ultimately this is a real change for the better that will bring cost efficiencies and not just a reshuffle of chairs?
Change is necessary but has to be the right change focused on both patients and the workforce to be effective.
Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice
Q: Are the ICB and NHS England redundancies really going to happen? What is driving this decision?
Redundancies are likely due to financial challenges faced by ICBs and the need to manage costs more effectively.
Transforming Global Market Access: Smarter Resource Management with Local Affiliates
Q: What advice would you give to other companies that are considering implementing this in a solution?
I would 100 percent recommend it. Go a little bit slowly and probably go a little bit slower than that.
Transforming Global Market Access: Smarter Resource Management with Local Affiliates
Q: What were you looking for when you first commissioned this value platform?
We wanted something that would bring our value dossiers and our value materials to life and stop them being a dusty thing that people didn't look at or didn't engage with.
Communicating value to US Payers: Insights for Pharma and Medtech
Q: How best to test and refine value messaging in the US?
Testing is best done with former payers in a safe space to ensure that messages resonate without bias.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Pharma Market Access Insights

What is Pharma Market Access Insights about and what kind of topics does it cover?

Focused on global healthcare markets, the series features discussions on essential market access strategies tailored for the pharmaceutical and medtech sectors. As experts from various industry roles share valuable insights, listeners gain knowledge about the complexities involved in healthcare pricing, stakeholder engagement, and innovative solutions for navigating market challenges. Notable themes include health economics, real-world evidence, payer dynamics, and the importance of timely communication and collaboration to enhance access for new therapies and technologies in a rapidly evolving landscape.

Where can I find podcast stats for Pharma Market Access Insights?

Rephonic provides a wide range of podcast stats for Pharma Market Access Insights. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Pharma Market Access Insights and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Pharma Market Access Insights get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Pharma Market Access Insights, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Pharma Market Access Insights?

Rephonic provides comprehensive predictive audience data for Pharma Market Access Insights, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Pharma Market Access Insights have?

To see how many followers or subscribers Pharma Market Access Insights has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Pharma Market Access Insights?

These podcasts share a similar audience with Pharma Market Access Insights:

1. Medicine and Science from The BMJ
2. JAMA Medical News
3. What the Health? From KFF Health News
4. Tradeoffs
5. The Readout Loud

How many episodes of Pharma Market Access Insights are there?

Pharma Market Access Insights launched 5 years ago and published 70 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Pharma Market Access Insights?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Pharma Market Access Insights?

Rephonic pulls ratings and reviews for Pharma Market Access Insights from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Pharma Market Access Insights?

Rephonic provides full transcripts for episodes of Pharma Market Access Insights. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Pharma Market Access Insights?

Recent guests on Pharma Market Access Insights include:

1. Tim Styche
2. Dan Vanderpool
3. Rory Davies
4. Jo Turl
5. Dr. Faris Al-Ramadani
6. Don Husereau

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days